JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged)
WKN A2PR30 | ISIN LU2053353665 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | IE00BF23BV98 | Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | +24,50 % | +24,55 % | 0,91 |
|
| 2 | IE00B42Z4531 | Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | +24,31 % | +24,57 % | 0,91 |
|
| 3 | IE00B3XLHR60 | Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares | +23,67 % | +24,56 % | 0,88 |
|
| 4 | LU0108459552 | Candriam Equities L Biotechnology, C - Distribution | +15,20 % | +22,27 % | 0,59 |
|
| 5 | LU0208607159 | Pictet - Biotech - P dy USD | +17,24 % | +27,59 % | 0,55 |
|
| 15 | LU2053353749 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | +1,42 % | +24,19 % | -0,03 |
|
| 16 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +0,85 % | +24,20 % | -0,05 |
|
| 17 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | -0,32 % | +22,90 % | -0,10 |
|
| 18 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | -0,39 % | +22,90 % | -0,11 |
|
| 19 | DE0008481862 | Allianz Biotechnologie - A - EUR | -1,25 % | +22,90 % | -0,15 |
|